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Primary ovarian pregnancy is a rare form of ectopic preg-
nancy. Preoperative diagnosis is extremely uncommon,
and our knowledge of the use of methotrexate (MTX)
therapy in such cases is, therefore, limited to sporadic
case reports. MTX therapy has recently achieved good
results in the treatment of ectopic pregnancies when
the following criteria were met: (1) hemodynamic sta-
bility, (2) no severe or persistent abdominal pain, (3)
commitment to follow-up until the ectopic pregnancy
resolved, and (4) normal baseline liver and renal func-
tion tests, as well as an absence of contraindications
to MTX treatment [1]. The Practice Committee of the
American Society for Reproductive Medicine recom-
mended that ovarian pregnancy should be definitively
diagnosed by surgical exploration, and MTX is, there-
fore, not a first-line treatment for this condition [1].
However, it is extremely difficult to make an accurate
preoperative diagnosis of ovarian pregnancy; thus, med-
ical treatment with systemic MTX injection, or expectant
observation using high-resolution transvaginal ultra-
sound (TVS) and serial serum β-human chorionic go-
nadotropin (β-hCG) monitoring is often suggested in
patients with an ectopic pregnancy at an unknown site,
who meet the above-mentioned criteria. We report a
case of suspected ovarian pregnancy diagnosed by TVS,
which met all the criteria, but failed multiple-dose sys-
temic MTX therapy. This suggests that systemic MTX
treatment might not be appropriate for the management
of ovarian pregnancies.
A woman aged 22 years visited our emergency
department because of lower abdominal pain and
abnormal spotting. She had a 2-year history of primary
infertility. Her last menstruation had been around 
5 weeks earlier, and a pregnancy test was positive. TVS
examination revealed an empty uterus and some fluid
accumulation in the cul-de-sac. Her initial serum β-hCG
level was 944 mIU/mL. She had stable vital signs and
symptom relief, and was, therefore, discharged for sub-
sequent observation on day 1, despite the possibility of
an ectopic pregnancy.
Two days after the initial diagnosis of a possible
ectopic pregnancy (day 3), her β-hCG level was
1,755 mIU/mL and TVS showed an empty uterine cav-
ity with suspected right adnexal sac-like tissue and a
nearby ovarian shadow (Figure 1). The patient refused
invasive management and was, therefore, advised to
receive an alternative therapy, such as single- or multi-
dose MTX treatment. A multidose MTX regimen (MTX
with leucovorin rescue) was initiated. The first dose of
MTX 50 mg/m2 intramuscular injection was given on
day 3. On day 4, her β-hCG was 2,238 mIU/mL and the
right ovarian sac-like shadow was enlarged. A second
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Figure 1. A small sac-like shadow, 0.8 cm in size, over the right
ovary near the posterior surface of the cortex, with some
fluid nearby.
MTX 50 mg/m2 injection was administered on day 5.
On day 6, her β-hCG level had fallen to 1,921 mIU/mL.
A third MTX 50 mg/m2 injection was prescribed on
day 7. On day 8, the patient complained of increased
vaginal bleeding and progressive abdominal pain, and
her β-hCG level was 1,993 mIU/mL. TVS showed an in-
creased mass and the presence of a halo sign with a
sac-like shadow on the ovarian contour (Figure 2).
Fluid accumulation in the cul-de-sac was not signifi-
cantly different from that seen on day 1. Laparoscopy
was advised, but the patient still refused to receive any
surgical intervention. A final dose of MTX 50 mg/m2
was, therefore, prescribed on day 9.
Acute onset of abdominal pain occurred on day 10.
The patient’s hemoglobin level dropped to 10.0 g/dL.
An urgent laparoscopy was arranged, and it revealed 
a hemoperitoneum of almost 800 mL and a 1.5-cm
swelling nodular lesion with active bleeding at the edge
of the right ovary (Figure 3). Laparoscopic wedge resec-
tion was performed uneventfully and she was discharged
the following day. The final pathology confirmed the
diagnosis of ovarian pregnancy. Menstruation resumed
29 days after surgery.
Ectopic pregnancy is one of the main causes of
pregnancy-related morbidity and mortality. Early diag-
nosis and treatment are vitally important for the han-
dling of such cases. However, preoperative diagnosis
remains challenging [2], especially in rare cases of
ovarian pregnancy, which are almost always diagnosed
after surgery [3].
Establishment of a diagnosis of primary ovarian preg-
nancy is strict and complicated. As with Spiegelberg’s
description in 1878, four criteria should be fulfilled,
including: (1) the fallopian tubes are normal, (2) the
gestational sac is anatomically sited in the ovary, (3) the
ovary is connected to the uterus by the utero-ovarian
ligament, and (4) the placental tissue is mixed with
ovarian cortex [4]. With the aid of careful TVS exami-
nation, the preoperative diagnosis of ovarian pregnancy
in this case could be achieved at about 5–6 weeks of
gestation (Figures 1 and 2). The embryo was just beside
the corpus luteum and beneath the ovarian cortex
(Figure 2B). This juxtafollicular and juxtacortical posi-
tion would contribute to an early occurrence of hemo-
peritoneum at an early gestational age.
An increase in the early diagnosis of ectopic preg-
nancy has been paralleled by increased conservative
medical treatment with MTX, especially in cases that
fulfill the following criteria: an ectopic mass of
< 35 mm; absence of a yolk sac; embryo or fetal heart
beat; and a β-hCG level < 3,000–5,000 mIU [5–7].
Medical treatment in our case was reasonable but,
nonetheless, failed. In a review of systemic MTX treat-
ment for ovarian pregnancy (Table) [8–11], there were
three successfully treated cases, but all of these received
laparoscopic procedures before systemic MTX treat-
ment. None were successfully treated with systemic
MTX alone, even though all were suitable candidates
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Figure 2. (A) The sac became larger with a halo sign and an echogenic shadow over the 2 o’clock position of the sac. (B) From
another angle, the echogenic shadow connecting to the sac showing the appearance of a corpus luteum.
Figure 3. Laparoscopy demonstrating the bleeding sac 
protruding from the right ovary.
for medical treatment. Based on these observations, it
seems likely that successful outcomes in patients with
ovarian pregnancies receiving MTX were attributable to
the laparoscopy, rather than the MTX. The ectopic preg-
nancy could have been removed or destroyed during
the laparoscopic procedures.
The value of direct injection of MTX, however, is
less clear. Based on promising experiences in manag-
ing other similar diseases [12–15], a direct injection of
MTX or other drugs, such as etoposide, directly over
the ectopic pregnancy site under ultrasound or laparo-
scopic guidance might be a possible treatment option.
We agree with the opinion of the Practice Committee
of the American Society for Reproductive Medicine,
who has decided that MTX is not a suitable first-line
treatment for ovarian pregnancy [1]. High-resolution
TVS and sensitive serum β-hCG evaluation, together
with a high index of suspicion, make early diagnosis of
ovarian pregnancy feasible, so avoiding the use of a rel-
atively ineffective treatment strategy such as systemic
MTX treatment [16].
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Table. Case reports of ovarian pregnancy treated by methotrexate therapy




β-hCG Mass size 
publication) diagnosis tool treatment (mIU/mL) (mm)
Shamma et al [2] No Laparoscopy No (?) MTX, IM Success 5,000 20
(1992)
Chelmow et al [9] No Laparoscopy Yes MTX, IM Success 29 10
(1994)
Habbu and Read [10] No Laparoscopy Yes MTX, IM Success 10,000 24
(2006)
Bagga et al [11] Yes by TVS Ultrasound Yes MTX, IM Failure 400 8
(2006)
Present case Yes by TVS Ultrasound Yes MTX, IM Failure 1,755 8
(2008)
b-hCG = b-human chorionic gonadotropin; MTX = methotrexate 50 mg/m2; IM = intramuscular injection; TVS = transvaginal ultrasound.
